Your arithmetic is totally flawed.
If half-on-half EBITDA is increased by a factor of 2.3 times, it certainly doesn't follow that NPAT increases by the same factor - which is what you seem to have done in deriving your $464m (1H NPAT = $202m x 2.3).
NPAT is a far smaller base than EBITDA, so it's multiplicand is a lot greater than 2.3x.
If you derived full-year NPAT from first principles, based on the guidance, you'll find JH2024 NPAT will be more like 3.3 times DH2023 NPAT)
.
.
Your arithmetic is totally flawed. If half-on-half EBITDA is...
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$24.98 |
Change
0.000(0.00%) |
Mkt cap ! $12.00B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 980 | $27.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $23.74 | 1005 | 4 |
View Market Depth
| Last trade - 09.40am 11/06/2024 (20 minute delay) ? |
| SHL (ASX) Chart |
Day chart unavailable